Skip to main content
Premium Trial:

Request an Annual Quote

Product Watch: Oct 13, 2011


Roche Diagnostics has launched its LightCycler Nano real-time PCR system in the US.

The 32-well LightCycler Nano is a benchtop system intended for "labs currently sharing time on another lab’s real-time PCR instrument," the company said in a statement.

Roche officials told PCR Insider prior to the system's launch that the Nano is intended to complement the company's LightCycler 480 and LightCycler 1536 real-time PCR systems (PCR Insider 6/2/2011).

Roche said it will begin accepting orders for LightCycler Nano instruments in early November.

Biogazelle has launched a qPCR-based service for analyzing long non-coding RNAs and long intergenic non-coding RNAs.

Specifically, the company said that it has developed validated qPCR assays for 1,666 lincRNAs and 52 lncRNAs. It runs the experiments in 5,184-well SmartChips from Wafergen and analyzes the data with its qbasePlus software.

Roche NimbleGen said this week that it will soon launch a pre-capture multiplex target enrichment protocol for its SeqCap product line that will allow multiple DNA samples to be barcoded and captured in a single SeqCap EZ Library reaction for exome or custom capture experiments.

The company said it also plans to launch a "more comprehensive" exome capture product, SeqCap EZ Exome Library v3.0, that will target 64 Mb of coding exons and miRNAs.

The company did not provide a launch date for the new products.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.